| Bayesian networks for risk prediction using real-world data: a tool for precision medicine P Arora, D Boyne, JJ Slater, A Gupta, DR Brenner, MJ Druzdzel Value in Health 22 (4), 439-445, 2019 | 145 | 2019 |
| Data capture and sharing in the COVID-19 pandemic: a cause for concern L Dron, V Kalatharan, A Gupta, J Haggstrom, N Zariffa, AD Morris, P Arora, ... The Lancet Digital Health 4 (10), e748-e756, 2022 | 47 | 2022 |
| Association between smoking history and overall survival in patients receiving pembrolizumab for first-line treatment of advanced non–small cell lung cancer S Popat, SV Liu, N Scheuer, A Gupta, GG Hsu, SV Ramagopalan, ... JAMA Network Open 5 (5), e2214046-e2214046, 2022 | 29 | 2022 |
| A study on the effect of architecture on maintainability of object-oriented systems P Hsia, A Gupta, C Kung, J Peng, S Liu Proceedings of International Conference on Software Maintenance, 4-11, 1995 | 28 | 1995 |
| Probabilistic graphical modeling for estimating risk of coronary artery disease: applications of a flexible machine-learning method A Gupta, JJ Slater, D Boyne, N Mitsakakis, A Béliveau, MJ Druzdzel, ... Medical Decision Making 39 (8), 1032-1044, 2019 | 23 | 2019 |
| Assessment of alectinib vs ceritinib in ALK-positive non–small cell lung cancer in phase 2 trials and in real-world data S Wilkinson, A Gupta, N Scheuer, E Mackay, P Arora, K Thorlund, ... JAMA Network Open 4 (10), e2126306-e2126306, 2021 | 18 | 2021 |
| Phosphatidylinositol 4,5-bisphosphate regulates cilium transition zone maturation in Drosophila melanogaster A Gupta, L Fabian, JA Brill Journal of cell science 131 (16), jcs218297, 2018 | 17 | 2018 |
| Comparative effectiveness of atezolizumab, nivolumab, and docetaxel in patients with previously treated non–small cell lung cancer S Ramagopalan, A Gupta, P Arora, K Thorlund, J Ray, V Subbiah JAMA Network Open 4 (11), e2134299-e2134299, 2021 | 14 | 2021 |
| The landscape of emerging randomized clinical trial evidence for COVID-19 disease stages: a systematic review of global trial registries A Dillman, MJ Zoratti, JJH Park, G Hsu, L Dron, G Smith, O Harari, ... Infection and Drug Resistance, 4577-4587, 2020 | 12 | 2020 |
| Bayesian network modelling study to identify factors influencing the risk of cardiovascular disease in Canadian adults with hepatitis C virus infection A Badawi, G Di Giuseppe, A Gupta, A Poirier, P Arora BMJ open 10 (5), e035867, 2020 | 11 | 2020 |
| Transportability of overall survival estimates from US to Canadian patients with advanced non–small cell lung cancer with implications for regulatory and health technology … SV Ramagopalan, S Popat, A Gupta, DJ Boyne, A Lockhart, G Hsu, ... JAMA Network Open 5 (11), e2239874-e2239874, 2022 | 9 | 2022 |
| Risk prediction using Bayesian networks: an immunotherapy case study in patients with metastatic renal cell carcinoma A Gupta, P Arora, D Brenner, J Vanderpuye-Orgle, DJ Boyne, ... JCO Clinical Cancer Informatics 5, 326-337, 2021 | 6 | 2021 |
| Quarles LD S Liu, A Gupta How fibroblast growth factor 23, 1637-1647, 0 | 6 | |
| The need for a practical approach to evaluate the effectiveness of COVID-19 vaccines for low-and middle-income countries S Nsanzimana, A Gupta, JP Uwizihiwe, J Haggstrom, L Dron, P Arora, ... The American Journal of Tropical Medicine and Hygiene 105 (3), 561, 2021 | 5 | 2021 |
| Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data DJ Boyne, DR Brenner, A Gupta, E Mackay, P Arora, R Wasiak, ... Annals of Epidemiology 78, 28-34, 2023 | 4 | 2023 |
| Artificial neural network to predict the effect of obesity on the risk of tuberculosis infection A Badawi, CJ Liu, AA Rihem, A Gupta Journal of public health research 10 (1), jphr. 2021.1985, 2021 | 4 | 2021 |
| Chemotherapy (ie, gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) for inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma, in a … A Gupta, S Yao, H Mackay, L Hopkins Cancer Care Ontario, 2012 | 2 | 2012 |
| Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers K Thorlund, S Duffield, S Popat, S Ramagopalan, A Gupta, G Hsu, P Arora, ... Journal of Comparative Effectiveness Research 13 (3), e230147, 2024 | 1 | 2024 |
| MSR125 bias adjusting for unmeasured confounders in synthetic control analysis (SCA) estimates of immunotherapy effectiveness in advanced non-small cell lung cancer (ANSCLC … S Kent, A Gupta, S Duffield, S Popat, J Ray, A Lockhart, M Hernán, ... Value in Health 25 (12), S374, 2022 | 1 | 2022 |
| POSC299 Transportability Analysis: A Principled Method for Transporting Treatment Effects Observed in One Real-World Dataset to Another A Gupta, S Ramagopalan, D Boyne, DR Brenner, WY Cheung, P Arora, ... Value in Health 25 (1), S207, 2022 | 1 | 2022 |
